Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Latest filing published 27 Dec 2018 for Novelion Therapeutics Inc., €253.
Filing timeline
BuySaleBroadfin Capital, LLC
Insider track record
Disclosed buys
0
Disclosed sells
3
Signal history
Broadfin Capital, LLC: trading record in brief
This profile gathers the share dealings of Broadfin Capital, LLC in Novelion Therapeutics Inc. The record holds 3 filings, for trades running from 24 December 2018 to 26 December 2018.
Every open-market trade on record is a sale: 3 sales worth €53k.
On 27 December 2018 came the latest disclosure, an open-market sale for €253 in Novelion Therapeutics Inc. Filings reach the SEDI feed a median of 1 day after the trade. The shorter that gap, the sooner other investors can see what insiders have done. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Companies and markets linked to Broadfin Capital, LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
400 shares@ CA$0.980.5% of flowCommon SharesTSXSEDI:3287971
83,245 shares@ CA$0.978498.2% of flowCommon SharesTSXSEDI:3287974
1,200 shares@ CA$0.93251.3% of flowCommon SharesTSXSEDI:3287973
3 of 3 declarations
